UK Parliament / Open data

Branded Health Service Medicines (Costs) (Amendment) Regulations 2023

I am sorry to interrupt the Minister’s flow. He said that we are having the fruitful discussions that the Prime Minister wants with the industry and that they are starting to progress. However, the industry itself is starting with a figure in the single figures, nowhere near 27%. I am curious as to why we are having this discussion about progressing these regulations, as they seem to be going in totally the opposite direction from the aspirations the Prime Minister has.

Type
Proceeding contribution
Reference
830 c1031 
Session
2022-23
Chamber / Committee
House of Lords chamber
Back to top